Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Romidepsin by Bristol-Myers Squibb for Thyroid Cancer: Likelihood of Approval
Romidepsin is under clinical development by Bristol-Myers Squibb and currently in Phase I for Thyroid Cancer. According to GlobalData, Phase...
Data Insights
Romidepsin by Bristol-Myers Squibb for Solid Tumor: Likelihood of Approval
Romidepsin is under clinical development by Bristol-Myers Squibb and currently in Phase I for Solid Tumor. According to GlobalData, Phase...